HK1208630A1 - 使用類視色素激動劑治療中性粒細胞減少症的方法 - Google Patents
使用類視色素激動劑治療中性粒細胞減少症的方法Info
- Publication number
- HK1208630A1 HK1208630A1 HK15109432.0A HK15109432A HK1208630A1 HK 1208630 A1 HK1208630 A1 HK 1208630A1 HK 15109432 A HK15109432 A HK 15109432A HK 1208630 A1 HK1208630 A1 HK 1208630A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- retinoid agonists
- treating neutropenia
- neutropenia
- treating
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 208000004235 neutropenia Diseases 0.000 title 1
- 150000004492 retinoid derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656815P | 2012-06-07 | 2012-06-07 | |
PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1208630A1 true HK1208630A1 (zh) | 2016-03-11 |
Family
ID=49712715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15109432.0A HK1208630A1 (zh) | 2012-06-07 | 2015-09-24 | 使用類視色素激動劑治療中性粒細胞減少症的方法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US11116738B2 (zh) |
EP (1) | EP2858636B1 (zh) |
JP (1) | JP6295249B2 (zh) |
KR (1) | KR102083046B1 (zh) |
CN (1) | CN104519879B (zh) |
AU (1) | AU2013270674B2 (zh) |
BR (1) | BR112014030279A2 (zh) |
CA (1) | CA2874850A1 (zh) |
ES (1) | ES2691493T3 (zh) |
HK (1) | HK1208630A1 (zh) |
MX (1) | MX365321B (zh) |
NZ (1) | NZ702415A (zh) |
RU (1) | RU2650962C2 (zh) |
WO (1) | WO2013185105A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10286039B2 (en) | 2014-02-18 | 2019-05-14 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014145295A1 (en) | 2013-03-15 | 2014-09-18 | Avisenna Cosmetics, Llc | Topical compositions for reducing aging effects |
MX2017012470A (es) | 2015-03-31 | 2018-03-23 | Syros Pharmaceuticals Inc | Metodos para estratificacion de pacientes para tratamiento con agonistas del receptor alfa de acido retinoico. |
US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
WO2018067946A1 (en) * | 2016-10-06 | 2018-04-12 | Syros Pharmaceuticals, Inc. | Methods of treating patients with a retinoic acid receptor-alpha agonist and an anti-cd38 antibody |
US20210123021A1 (en) * | 2018-01-26 | 2021-04-29 | Agency For Science, Technology And Research | Neutrophil subtypes |
CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5691196A (en) | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
EP0957918A1 (en) | 1996-12-19 | 1999-11-24 | American Cyanamid Company | Method of treating or inhibiting neutropenia |
WO2002020767A2 (en) | 2000-09-08 | 2002-03-14 | Massachusetts Institute Of Technology | G-csf analog compositions and methods |
US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
AU2004238146A1 (en) | 2003-05-16 | 2004-11-25 | Kyowa Hakko Kogyo Co., Ltd. | Preventive and/or remedy for diseases accompanied by tissue destruction |
EP1621191A1 (en) | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
JP2008509928A (ja) | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆/幹細胞を動員するためのケモカインの組み合わせ |
MX2007006540A (es) | 2004-12-02 | 2008-01-31 | Venus Remedies Ltd | Composiciones para combatir la resistencia a antibioticos mediada por beta-lactamasa usando inhibidores de beta-lactamasa utiles para inyeccion. |
US20090111786A1 (en) | 2004-12-03 | 2009-04-30 | Glass Christopher K | Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
CA2651487A1 (en) * | 2006-05-16 | 2007-11-29 | Vitae Pharmaceuticals, Inc. | Methods for treating chemotherapy and radiation therapy side effects |
NZ580209A (en) | 2007-03-30 | 2011-11-25 | Tmrc Co Ltd | Tamibarotene capsule preparation |
WO2009070844A1 (en) * | 2007-12-06 | 2009-06-11 | Csl Limited | Method of inhibition of leukemic stem cells |
EP2334814A4 (en) | 2008-09-05 | 2012-04-25 | Solulink Biosciences Inc | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA INJURIES |
CN102612371B (zh) | 2009-10-19 | 2014-03-19 | 莱拉营养食品有限公司 | 含有多聚乙酰的提取物,分馏物和混合物及它们的应用 |
RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术(上海)有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
CA2826386C (en) | 2011-02-08 | 2020-04-28 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
WO2013169864A2 (en) * | 2012-05-08 | 2013-11-14 | Lycera Corporation | TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE |
US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
CN104758922A (zh) | 2014-01-03 | 2015-07-08 | 上海泽生科技开发有限公司 | 纽兰格林制剂的配方 |
US10286039B2 (en) | 2014-02-18 | 2019-05-14 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
-
2013
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh active Active
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja active Active
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko active IP Right Grant
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en active Application Filing
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned
-
2015
- 2015-09-24 HK HK15109432.0A patent/HK1208630A1/zh not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11116738B2 (en) | 2012-06-07 | 2021-09-14 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
US10286039B2 (en) | 2014-02-18 | 2019-05-14 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
Also Published As
Publication number | Publication date |
---|---|
CA2874850A1 (en) | 2013-12-12 |
ES2691493T3 (es) | 2018-11-27 |
EP2858636A1 (en) | 2015-04-15 |
US20150164836A1 (en) | 2015-06-18 |
EP2858636A4 (en) | 2016-06-01 |
JP2015523346A (ja) | 2015-08-13 |
NZ702415A (en) | 2016-04-29 |
JP6295249B2 (ja) | 2018-03-14 |
CN104519879A (zh) | 2015-04-15 |
BR112014030279A2 (pt) | 2017-09-12 |
KR102083046B1 (ko) | 2020-02-28 |
RU2650962C2 (ru) | 2018-04-18 |
CN104519879B (zh) | 2018-10-02 |
MX2014014930A (es) | 2015-07-06 |
AU2013270674A1 (en) | 2014-12-18 |
US11116738B2 (en) | 2021-09-14 |
AU2013270674B2 (en) | 2017-12-07 |
WO2013185105A1 (en) | 2013-12-12 |
MX365321B (es) | 2019-05-29 |
RU2014153988A (ru) | 2016-07-27 |
EP2858636B1 (en) | 2018-09-05 |
KR20150035983A (ko) | 2015-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212879A1 (zh) | 電外科設備 | |
HK1214504A1 (zh) | 用於治療貧血的方法 | |
EP2766018A4 (en) | RXR AGONIST COMPOUNDS AND ASSOCIATED METHODS | |
EP2787497A4 (en) | DEFAULT ASSESSMENT APPARATUS | |
HK1208630A1 (zh) | 使用類視色素激動劑治療中性粒細胞減少症的方法 | |
EP2871630A4 (en) | DEVICE FOR MONITORING MONITORING | |
ZA201405746B (en) | Rafamycin analogs and methods for making same | |
GB201218666D0 (en) | Apparatus | |
PL2825704T3 (pl) | Urządzenie do oczyszczania drogi | |
GB201220673D0 (en) | Apparatus | |
GB201202147D0 (en) | Interface apparatus | |
PL2809816T3 (pl) | Sposób ekspresji | |
EP2880048A4 (en) | METHOD | |
PL2917455T3 (pl) | Aparat pobierający próbki | |
GB201300914D0 (en) | Apparatus | |
GB201202198D0 (en) | Method | |
EP2813146A4 (en) | DEVICE FOR SLAUGHTERING FISH | |
GB201218575D0 (en) | Nephroureterectomy apparatus | |
HK1209999A1 (zh) | 設備 | |
GB201311406D0 (en) | Club-swing practice apparatus | |
GB201215796D0 (en) | Apparatus | |
HK1209040A1 (zh) | 用於治療前庭毒性的方法 | |
GB201116152D0 (en) | Cannabinoid-2-receptor agonists | |
ZA201409241B (en) | Fishing apparatus | |
TWI561687B (en) | An electroplating method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230609 |